GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OSTO:RAY B) » Definitions » Cyclically Adjusted PS Ratio

RaySearch Laboratories AB (OSTO:RAY B) Cyclically Adjusted PS Ratio : 13.60 (As of Jul. 06, 2025)


View and export this data going back to 1991. Start your Free Trial

What is RaySearch Laboratories AB Cyclically Adjusted PS Ratio?

As of today (2025-07-06), RaySearch Laboratories AB's current share price is kr343.50. RaySearch Laboratories AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr25.25. RaySearch Laboratories AB's Cyclically Adjusted PS Ratio for today is 13.60.

The historical rank and industry rank for RaySearch Laboratories AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

OSTO:RAY B' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.64   Med: 6.72   Max: 30.47
Current: 13.6

During the past years, RaySearch Laboratories AB's highest Cyclically Adjusted PS Ratio was 30.47. The lowest was 2.64. And the median was 6.72.

OSTO:RAY B's Cyclically Adjusted PS Ratio is ranked worse than
97.36% of 341 companies
in the Healthcare Providers & Services industry
Industry Median: 1.31 vs OSTO:RAY B: 13.60

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

RaySearch Laboratories AB's adjusted revenue per share data for the three months ended in Mar. 2025 was kr9.675. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr25.25 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


RaySearch Laboratories AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for RaySearch Laboratories AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB Cyclically Adjusted PS Ratio Chart

RaySearch Laboratories AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.26 3.71 3.58 4.09 8.76

RaySearch Laboratories AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.07 6.02 6.46 8.76 8.91

Competitive Comparison of RaySearch Laboratories AB's Cyclically Adjusted PS Ratio

For the Health Information Services subindustry, RaySearch Laboratories AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Cyclically Adjusted PS Ratio falls into.


;
;

RaySearch Laboratories AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

RaySearch Laboratories AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=343.50/25.25
=13.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RaySearch Laboratories AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, RaySearch Laboratories AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=9.675/132.8245*132.8245
=9.675

Current CPI (Mar. 2025) = 132.8245.

RaySearch Laboratories AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 2.375 99.995 3.155
201509 2.917 100.228 3.866
201512 3.810 100.276 5.047
201603 2.793 100.751 3.682
201606 3.466 101.019 4.557
201609 3.656 101.138 4.801
201612 5.596 102.022 7.286
201703 3.716 102.022 4.838
201706 4.159 102.752 5.376
201709 3.258 103.279 4.190
201712 5.979 103.793 7.651
201803 3.391 103.962 4.332
201806 4.114 104.875 5.210
201809 4.389 105.679 5.516
201812 6.401 105.912 8.028
201903 5.041 105.886 6.323
201906 5.532 106.742 6.884
201909 4.211 107.214 5.217
201912 6.840 107.766 8.430
202003 6.092 106.563 7.593
202006 4.777 107.498 5.902
202009 3.475 107.635 4.288
202012 4.662 108.296 5.718
202103 4.728 108.360 5.795
202106 4.509 108.928 5.498
202109 3.979 110.338 4.790
202112 5.500 112.486 6.494
202203 6.040 114.825 6.987
202206 4.674 118.384 5.244
202209 6.151 122.296 6.681
202212 7.712 126.365 8.106
202303 6.714 127.042 7.020
202306 7.019 129.407 7.204
202309 7.376 130.224 7.523
202312 8.740 131.912 8.800
202403 7.502 132.205 7.537
202406 9.291 132.716 9.299
202409 8.555 132.304 8.589
202412 9.412 132.987 9.400
202503 9.675 132.825 9.675

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


RaySearch Laboratories AB  (OSTO:RAY B) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


RaySearch Laboratories AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


RaySearch Laboratories AB Business Description

Traded in Other Exchanges
Address
Eugeniavagen 18C, P.O. Box 3297, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia Pacific, Europe and the rest of the world.

RaySearch Laboratories AB Headlines

No Headlines